SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
10-Q | Quarterly report which provides a continuing view of a company's financial position |
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT | |
8-K | Report of unscheduled material events or corporate event |
View HTML | |
8-K | Report of unscheduled material events or corporate event |
View HTML | |
EFFECT | EFFECT |
View HTML | |
CORRESP | CORRESP |
View HTML | |
S-3/A | Pre-effective amendment to an S-3 filing |
View HTML | |
CORRESP | CORRESP |
View HTML | |
UPLOAD | UPLOAD |
View HTML | |
S-3 | Simplified registration form |
View HTML | |
CT ORDER | CT ORDER |
View HTML |
Displaying 821 - 830 of 958 results
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.